Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


GreenScreen HC

Product Image
Product Description

GreenScreen® HC is an accurate and fast in vitro human cell-based assay for the assessment of genotoxicity and cytotoxicity of compounds and mixtures.

The assay detects substances that are capable of causing damage to genetic material (DNA) within a cell. GreenScreen HC uses the human-derived, p53 competent, TK6 cell line to host a patented green fluorescent protein (GFP) reporter  system which exploits the proper regulation of the GADD45a gene.

Exposure to a genotoxic compound increases the expression of GADD45a and hence the induction of GFP production in the test strain. Simultaneous quantification of relative cell density or cell viability allows assessment of cytotoxicity.

•    Unique combination of high specificity and high sensitivity for genotoxicity
•    Detects all mechanistic classes of genotoxin (mutagens, aneugens and clastogens)
•    Most accurate genotoxicity screening test available
•    Simple, robust and fast protocol
•    Low sample requirement

The 96-well microplate format takes about 20 minutes to prepare and delivers results after a 48 hour incubation. A single microplate is used for the simultaneous testing of 4 compounds over 9 serial dilutions. The protocol is readily automated using standard laboratory equipment.

Product GreenScreen HC
Company Gentronix Ltd.
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Gentronix Ltd.
BioHub at Alderley Park Alderley Edge Cheshire SK10 4TG United Kingdom

Tel: +44 (0)1625 238700
Fax: +44 (0)1625 238701
Email: info@gentronix.co.uk



Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!